Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview
暂无分享,去创建一个
Anwar H Nassar | Ghina S Ghazeeri | Zeina Younes | Johnny T Awwad | A. Nassar | Z. Younes | J. Awwad | G. Ghazeeri
[1] C. Glueck,et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. , 2001, Fertility and sterility.
[2] C. Glueck,et al. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. , 1999, Metabolism: clinical and experimental.
[3] J. Lekakis,et al. Metformin administration improves endothelial function in women with polycystic ovary syndrome. , 2005, European journal of endocrinology.
[4] Y. Diamant,et al. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. , 1982, European journal of obstetrics, gynecology, and reproductive biology.
[5] S. Berga,et al. Does PCOS have developmental origins? , 2012, Fertility and sterility.
[6] A. Lanzone,et al. Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. , 1998, Human reproduction.
[7] M. Eijkemans,et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. , 2006, Human reproduction update.
[8] T. Gurgan,et al. Pregnancy in infertile PCOD patients. Complications and outcome. , 1997, The Journal of reproductive medicine.
[9] P. Romundstad,et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. , 2010, The Journal of clinical endocrinology and metabolism.
[10] R. Homburg. Pregnancy complications in PCOS. , 2006, Best practice & research. Clinical endocrinology & metabolism.
[11] G. Erdogan,et al. Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study. , 2009, Fertility and sterility.
[12] N. Goldenberg,et al. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. , 2002, Human reproduction.
[13] P. Claman,et al. Polycystic ovary disease and the risk of pregnancy-induced hypertension. , 2000, The Journal of reproductive medicine.
[14] S. Carlsen,et al. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double‐blind study , 2008, Scandinavian journal of clinical and laboratory investigation.
[15] E. Dempsey,et al. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity , 2009, European Journal of Pediatrics.
[16] E. Çalışkan,et al. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. , 2002, Fertility and sterility.
[17] N. Goldenberg,et al. Metformin, pre‐eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[18] D. Jakubowicz,et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome , 2002, The Journal of clinical endocrinology and metabolism.
[19] A. Lanzone,et al. Polycystic ovary disease. A risk factor for gestational diabetes? , 1995, The Journal of reproductive medicine.
[20] D. Cibula,et al. Pregnancy outcome in women with PCOS and in controls matched by age and weight. , 2003, Human reproduction.
[21] C. Glueck,et al. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. , 2008, Fertility and sterility.
[22] F. Orio,et al. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. , 2009, Fertility and sterility.
[23] M. Costello,et al. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. , 2003, Fertility and sterility.
[24] V. Hiilesmaa,et al. Obstetric outcome in women with polycystic ovarian syndrome. , 2001, Human reproduction.
[25] C. Glueck,et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. , 2002, Fertility and sterility.
[26] M. Eijkemans,et al. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. , 2010, Human reproduction.
[27] K. Salvesen,et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. , 2004, Human reproduction.
[28] Elizabeth M. Jackson,et al. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. , 2006, Fertility and sterility.
[29] M. Maliqueo,et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. , 2007, Human reproduction.
[30] S. Weerakiet,et al. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[31] J. Clore,et al. The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome , 1989, American journal of obstetrics and gynecology.
[32] D. Goulis,et al. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. , 2009, Fertility and sterility.
[33] M. Kashanian,et al. Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome. , 2008, Diabetes research and clinical practice.
[34] G. Ertzeid,et al. Impact of Insulin Resistance on Pregnancy Complications and Outcome in Women with Polycystic Ovary Syndrome , 2003, Gynecologic and Obstetric Investigation.
[35] L. Sanchez-Ramos,et al. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. , 2011, American journal of obstetrics and gynecology.
[36] H. Burger,et al. Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.
[37] F. Orio,et al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. , 2010, Fertility and sterility.
[38] G. Dekker,et al. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[39] N. Goldenberg,et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. , 2004, Human reproduction.
[40] F. Nawaz,et al. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? , 2008, The journal of obstetrics and gynaecology research.
[41] R. Norman,et al. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. , 2001, Human reproduction.
[42] J. Nestler. Metformin for the treatment of the polycystic ovary syndrome. , 2008, The New England journal of medicine.
[43] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[44] R. Pasquali,et al. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. , 2010, European journal of obstetrics, gynecology, and reproductive biology.
[45] M. McMahon,et al. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. , 1999, Obstetrics and gynecology.
[46] R. Azziz,et al. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. , 2006, Fertility and sterility.
[47] R. Azziz,et al. Use of metformin in polycystic ovary syndrome. , 2008, American journal of obstetrics and gynecology.
[48] N. Turhan,et al. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[49] K. Lesser,et al. Association between polycystic ovary syndrome and glucose intolerance during pregnancy. , 1997, The Journal of maternal-fetal medicine.
[50] W. Evans,et al. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. , 2001, Fertility and sterility.
[51] D. Jakubowicz,et al. Insulin Resistance and Early Pregnancy Loss in Polycystic Ovary Syndrome , 2007 .
[52] A. Duleba,et al. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. , 2006, Fertility and sterility.
[53] A. Seifalian,et al. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. , 2007, Human reproduction.
[54] G. Escobar,et al. Increased Prevalence of Gestational Diabetes Mellitus Among Women With Diagnosed Polycystic Ovary Syndrome , 2006, Diabetes Care.